Lactobacillus Bacteremia, Clinical Significance, and Patient Outcome, with Special Focus on Probiotic L. Rhamnosus GG
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Lactobacillus bacteremia is a rare entity, and its clinical significance is poorly defined. We have reviewed the risk factors and outcome for 89 case patients with Lactobacillus bacteremia. Species characterization was done in 53% of the cases, revealing 25 L. rhamnosus strains and 22 other Lactobacillus species. In 11 cases, the strain was identical with the probiotic L. rhamnosus GG. In 82% of the cases, the patients had severe or fatal comorbidities. Predisposing factors to bacteremia were immunosuppression, prior prolonged hospitalization, and prior surgical interventions. No significant differences were observed in these predisposing factors or clinical features between patients with cases associated with the various Lactobacillus species, other than higher C-reactive protein values in patients with L. rhamnosus bacteremia. Mortality was 26% at 1 month and was 48% at 1 year. In multivariate analysis, severe underlying diseases were a significant predictor for mortality (odds ratio [OR], 15.8), whereas treatment with antimicrobials effective in vitro was associated with lower mortality (OR, 0.22). We conclude that lactobacilli in blood cultures are of clinical significance and that their susceptibility should guide decisions about antimicrobial treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The source of these infections has sometimes been attributed to the use of Lactobacillus-containing probiotics [9,10,11].”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [9]
In the citing paper
“In contrast, treatment with antibiotics effective in vitro was associated with lower mortality (OR = 0.22) [9].”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [9]
In the citing paper
“Salminen et al. reviewed the risk factors and outcomes for LB using multivariate analysis and found severe underlying diseases, which were primarily malignancies or serious gastrointestinal disorders, and were a significant predictor for mortality (odds ratio [OR] = 15.8).”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [9]
In the citing paper
“In 82% of the cases, the patients had severe or fatal comorbidities.”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [9]
In the citing paper
“LB is usually associated with patients who have comorbidities or suppressed immune systems [6,7,9,28,29,30].”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [9]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Gram-Negative Bacteremia: I. Etiology and Ecology
McCABE, W. R. (1962) · Archives of Internal Medicine · doi:10.1001/archinte.1962.03620240029006 · Cited by 1,362
Walter, J., Tannock, G. W., Tilsala-Timisjarvi, A., Rodtong, S., Loach, D. M., Munro, K., & Alatossava, T. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.1.297-303.2000 · Cited by 607 · cited 1×
“casei [15], Lactobacillus fermentum [16], Lactobacillus gasseri, and Lactobacillus zeae [17] were performed to identify the strains.”
BackgroundAntibacterial susceptibility tests : Dilution and disk diffusion methods.
Woods, G. (1995) · Medical Entomology and Zoology · Cited by 556
Lactic acid bacteria and human clinical infection
Aguirre, M., & Collins, M. D. (1993) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1993.tb02753.x · Cited by 425 · cited 2×
“they have been regarded as contaminants [1].”
BackgroundSalminen, M. K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V., & Järvinen, A. (2002) · Clinical Infectious Diseases · doi:10.1086/342912 · Cited by 419 · cited 6×
“rhamnosus species–specific PCR used, and typing by PFGE have been described elsewhere [11].”
BackgroundMethodInfluentialSelf-citationLiver Abscess Due to a Lactobacillus rhamnosus Strain Indistinguishable from L. rhamnosus Strain GG
Rautio, M., Jousimies‐Somer, H., Kauma, H., Pietarinen, I., Saxelin, M., Tynkkynen, S., & Koskela, M. (1999) · Clinical Infectious Diseases · doi:10.1086/514766 · Cited by 327
Self-citationSong, Y. (2000) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(00)00196-8 · Cited by 313 · cited 1×
“casei [15], Lactobacillus fermentum [16], Lactobacillus gasseri, and Lactobacillus zeae [17] were performed to identify the strains.”
BackgroundLactobacillus bacteremia and endocarditis: Review of 45 cases
Husni, R. N., Gordon, S. M., Washington, J. A., & Longworth, D. L. (1997) · Clinical Infectious Diseases · doi:10.1086/516109 · Cited by 270 · cited 7×
“The majority of Lactobacillus bacteremia cases occurred within 48 h after hospitalization, whereas most cases have previously been reported to be nosocomial [2].”
BackgroundResultInfluentialLactobacillus endocarditis caused by a probiotic organism
Mackay, A. D., Taylor, M. B., Kibbler, C. C., & Hamilton-Miller, J. M. T. (1999) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1999.tb00144.x · Cited by 264
Research works printed but not linked: 4
- Song YL, 2000, FEMS Microbiol Lett, 187, 167
- Jorgensen JH, 1999, Washington DC: American Society for Microbiology, 1526
- Durack DT, 1994, Duke Endocarditis Service. Am J Med, 96, 200
- Gasser F, 1994, Bull Inst Pasteur, 92, 45
Cited by
Items 401–426 of 426
Colitis por Clostridium difficile
Efron, P. A., & Mazuski, J. E. (2009) · Clínicas quirúrgicas de Norteamérica
Abraham, S. S., Thomas, M., Mathew, R., Jose, R. A., Goswami, T., & Jacob, A. A. (2022) · Journal of The Academy of Clinical Microbiologists · doi:10.4103/jacm.jacm_54_21
Probiotics in Infectious Diseases
Fong, I. W. (2009) · Springer eBooks · doi:10.1007/978-0-387-84841-9_10
Saarela, M. (2007) · Nutraceutical science and technology · doi:10.1201/9781420015584.ch29
Owens, R. C., Valenti, A. J., & Wilcox, M. H. (2007) · Infectious disease and therapy · doi:10.3109/9781420017236.011
Ilboudo, C. M., & Bratcher, D. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00133-6 · Cited by 1
Probiotics for Infection Prevention in Critically Ill and Trauma Patients: A Concise Review
Vitko, H. A., Troxell, J. J., & Sherwood, P. R. (2023) · Journal of Trauma Nursing · doi:10.1097/jtn.0000000000000744 · Cited by 2
“Some early case reports suggest that probiotic supplementation may potentially be associated with fungemia, bacteremia, and sepsis, but these are relatively few (Hempel et al., 2011; Salminen et al., 2003; Thygesen et al., 2012).”
BackgroundKarolczyk, P., Kotarba, M., Świątek, M., Kaczmarek-Zalewska, A., Janicka, N., Jońca, B., Matkowski, I., & Karłowicz-Bodalska, K. (2023) · Farmacja Polska · doi:10.32383/farmpol/175122
Fukuda, Y., Morioka, H., Yamamoto, S., Iguchi, M., Umeda, S., Asahara, T., Kanda, K., Oka, K., Nakayama, G., & Yagi, T. (2024) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2023.12.015 · Cited by 1
Nonprobiotic Bifidobacterium bloodstream infection in a lymphoma patientPreprint
Imataki, O., & Uemura, M. (2024) · Research Square · doi:10.21203/rs.3.rs-3884275/v1
Perkins, J. B., Ravi, K., Guo, C., Oh, G. J., Rodriguez, B. G., Gurczynski, S. J., Weinberg, J. B., Huffnagle, G. B., O’Dwyer, D. N., Moore, B. B., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.06.602351
The Various Healthcare Applications of the Genus Lactobacillus
Narasimha, S. V., Zackria, R., Chadha, R., Gheriani, A. G., Johnson, L., Pattison, R., Kim, A., Chen, G., Ryan, J., & Shih, D. Q. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.115299 · Cited by 3
Anaerobic Non‐Spore‐Forming Gram‐Positive Rods
Butler‐Wu, S. M., & She, R. C. (2023) · Wiley eBooks · doi:10.1002/9781683670438.mcm0055
A Case of Sepsis Caused by Lactobacillus rhamnosus
韦, 晓. (2025) · Asian Case Reports in Emergency Medicine · doi:10.12677/acrem.2025.132030
Lactobacillus Bacteremia: A Challenging Condition for Pediatrician
Sandei, M., Mazzetti, G., Novara, C., Valenti, C., Liguori, S. A., Bordese, R., Denina, M., & Silvestro, E. (2025) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004971
Rehan, M. A., Bagwell, J. T., Wachter, S. B., & Jubbal, S. S. (2026) · Case Reports in Infectious Diseases · doi:10.1155/crdi/9295802
“In a retrospective analysis of 89 patients with Lactobacillus bacteremia, Salminen et al. (2004) Several risk factors for Lactobacillus bacteremia and endocarditis have been reported in medical literature [5, 9, 11–15] including immunosuppression (current or chronic immunosuppressive therapy,…”
When probiotics turn deadly: a case of Lacticaseibacillus rhamnosus sepsis in a burn patient
Janák, D., Bakalář, B., Fridrichová, M., Zwinsova, B., Zajíček, R., Lipový, B., & Linhartová, P. B. (2026) · Folia Microbiologica · doi:10.1007/s12223-026-01445-x · Cited by 1
An elderly hemodialysis patient with Lactobacillus rhamnosus bacteremia: a case report
Morita, M., Muratsu, J., Uchida, M., Hayashi, M., Nariyama, A., Okamoto, K., Wada, T., Yamato, M., & Shigematsu, T. (2026) · Renal Replacement Therapy · doi:10.1186/s41100-026-00732-0
Duggar, M., Leardini, D., Muratore, E., Margolis, E. B., & Masetti, R. (2026) · Pediatric Transplantation · doi:10.1111/petr.70371
Qiao, Q., Ning, Y.-C., Zhu, S.-N., Ma, J., Chen, W., Tian, W., Wang, C. Y., Wu, Y.-F., & Li, S. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1814969
Ding, Y., Huang, X., Zhao, Y., Dong, R., Zhou, C., Wu, Y., Du, H., Wan, J., Liu, Y., & Xu, A. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.06.050
Kim, H., & Diederich, M. F. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118369
Microbial exopolysaccharides as bioactive modulators of intestinal health: a systematic review
McGovern, C. J., & Tako, E. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1885879
“Similar studies have suggested that Lactobacillus-associated bacteremia may be linked to probiotic supplementation, highlighting the need for caution in the use of probiotics in individuals with compromised gut barriers (11, 12).”
The failure aspects of viable probiotics in foods, supplements, and drugs
Moghadam, S. K., Houshyar, J., Alikhah, H., Keisan, S., & Rad, A. H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29835-6.00011-3
Demchenkova, M., Semshchikova, Y. P., Барзунова, Т. В., Kozlov, Y. А., & Savintseva, I. N. (2026) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2026.2.338-343
Metadata
- Authors
- Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A.
- Affiliations
- Helsinki University Hospital (FI)
- University of Helsinki (FI)
- Valio (Finland) (FI)
- Corresponding author
- Salminen, Minna K.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01
- Volume
- 38
- Issue
- 1
- Pages
- 62-69
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2141720872
- Cited by
- 426
- References
- 29
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 19 · 2023: 16 · 2022: 23 · 2021: 19 · 2020: 17 · 2019: 19 · 2018: 15 · 2017: 19 · 2016: 21 · 2015: 18 · 2014: 19 · 2013: 15 · 2012: 19
- FWCI
- 28.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- Lactobacillus rhamnosus GG, probiotics, mortality, comorbidities, immunosuppression, C-reactive protein, antimicrobial susceptibility, antimicrobial therapy
- MeSH terms
- Anti-Bacterial Agents, Female, Humans, Lactobacillus, Male, Middle Aged, Multivariate Analysis, Bacteremia, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.